{"id":11076,"date":"2021-07-14T09:00:35","date_gmt":"2021-07-14T14:00:35","guid":{"rendered":"https:\/\/backup.primeaction.com\/sp\/?p=11076"},"modified":"2021-07-07T10:29:56","modified_gmt":"2021-07-07T15:29:56","slug":"bayer-busca-innovar-en-la-industria-farmaceutica","status":"publish","type":"post","link":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/","title":{"rendered":"Bayer busca innovar en la industria farmac\u00e9utica"},"content":{"rendered":"

La idea de Bayer en lo que queda del 2021 es seguir manteniendo el \u00e9xito que tuvo en el primer trimestre en sus tres negocios: consumo, farmac\u00e9utica y agricultura y tambi\u00e9n ocupar una buena posici\u00f3n en las \u00e1reas de nutrici\u00f3n y salud.<\/p>\n

As\u00ed lo revel\u00f3 Christian Meyer, presidente de Bayer en los pa\u00edses andinos, Centroam\u00e9rica y el Caribe.<\/p>\n

\u201cEstos a\u00f1os, el pasado y este, nos han dejado como una compa\u00f1\u00eda en cambio porque la transformaci\u00f3n que ahora requieren los negocios por el impacto de la digitalizaci\u00f3n y la aceleraci\u00f3n que le ha dado a las compa\u00f1\u00edas ya que ha modificado la forma en la que nos conectamos con nuestros clientes en todas las divisiones\u201d, se\u00f1al\u00f3 el directivo.<\/p>\n

De acuerdo con Meyer, la idea de estos cambios es fomentar la innovaci\u00f3n de la compa\u00f1\u00eda, \u201cnosotros vivimos de eso en nuestros negocios y es lo que seguiremos haciendo en Colombia con cerca de 2 millones de d\u00f3lares para infraestructura en la planta de Barranquilla y en innovaci\u00f3n de agricultura estaremos invirtiendo casi un mill\u00f3n de d\u00f3lares y casi medio mill\u00f3n de euros para traer productos en farma\u201d.<\/p>\n

En la divisi\u00f3n de Farmac\u00e9utica tras la pandemia el impacto se ha sentido de una manera fuerte, los paciente ten\u00edan miedo de seguir sus tratamientos o de consultar sus dolencias. \u201cEste efecto se sinti\u00f3 mucho en el \u00e1rea de oncolog\u00eda o de oftalmolog\u00eda y ha costado incluso vidas por no tener acceso al sistema de salud. Ahora que vemos una pandemia con mucha fuerza en algunas zonas es importante seguir en la atenci\u00f3n. Vimos una ca\u00edda fuerte en el segmento, pero tambi\u00e9n la pandemia nos dejo valorando la salud de una manera diferente, ahora las personas est\u00e1n m\u00e1s dispuestas a invertir m\u00e1s, los gobiernos hacen otros esfuerzos y eso ha sido positivo\u201d,dijo.<\/p>\n

De otro lado, el costo de la pandemia ha generado muchos gastos y las empresas tambi\u00e9n est\u00e1n dispuestas a sanearlos.<\/p>\n

\u201cEntre los retos m\u00e1s importantes que tengo, est\u00e1 el llevar la apuesta de Bayer en la innovaci\u00f3n, porque no queremos traer copias al mercado, sino darle un valor adicional a los productos para mejorar la vida de los pacientes y con eso darle un mejor impacto\u201d, apunt\u00f3.<\/p>\n

El trabajo en los tratamientos contra el coronavirus que si bien no desarrolla Bayer tambi\u00e9n cambiar\u00e1 el paradigma al futuro.<\/p>\n

\u201cNo estamos en vacunas o tratamientos contra la covid-19 pero la industria si ha cambiado con la contribuci\u00f3n en esta pandemia, con el desarrollo de las vacunas en tan corto tiempo y ha sido impresionante, adem\u00e1s de la reputaci\u00f3n que se le ha dado a las marcas\u201d agreg\u00f3 <\/p>\n

Meyer fue enf\u00e1tico, en que si bien las personas tienen preferencia por una u otra vacuna es mejor tenerla. \u201cEs normal que esto ocurra, nos pasa a nosotros con el si es Bayer, es bueno. Lo que hemos visto globalmente es la confianza que se le da a los productos con los que ya se est\u00e1 familiarizado. Siempre es mejor ser vacunado con un producto a no serlo, solo as\u00ed se salvar\u00e1n las vidas y es mejor vacunarse m\u00e1s en la condici\u00f3n actual de la escasez y m\u00e1s en un pa\u00eds como Colombia\u201d, se\u00f1al\u00f3. <\/p>\n

La intenci\u00f3n por ejemplo con la planta de Barranquilla es fortalecer la capacidad pues desde all\u00ed se exportan Fitosanitarios a 15 pa\u00edses, tambi\u00e9n se busca traer nuevos productos y seguir con los estudios cl\u00ednicos.<\/p>\n

CERCA DE 5 PRODUCTOS EN LISTA DE ESPERA EN EL PA\u00cdS <\/p>\n

De acuerdo con Christian Meyer, presidente de Bayer en los pa\u00edses andinos, Centroam\u00e9rica y el Caribe, hay al menos cinco productos de diversos tratamientos en lista de espera para ser autorizados en Colombia.<\/p>\n

\u201cDos de estos son en Oncolog\u00eda, dos m\u00e1s en el \u00e1rea Cardiovascular y uno m\u00e1s en Oftalmolog\u00eda\u201d, dijo.<\/p>\n

Sobre el compromiso de la empresa en el pa\u00eds en conde cumple 109 a\u00f1os apunt\u00f3 que la idea es continuar con lo hecho. \u201cEl a\u00f1o pasado invertimos un mill\u00f3n de euros en 7 estudios cl\u00ednicos en 60 diferentes centros de investigaci\u00f3n en Colombia y la verdad es que nos gustar\u00eda la inversi\u00f3n en los distintos segmentos fuera m\u00e1s\u201d, expuso. De otro lado, la empresa tambi\u00e9n participa en la compra de vacunas para inmunizar a cerca de 500 empleados.<\/p>\n","protected":false},"excerpt":{"rendered":"

Adem\u00e1s de esta l\u00ednea, la firma tiene la intenci\u00f3n de impulsar su crecimiento tambi\u00e9n en la de consumo y agricultura.<\/p>\n","protected":false},"author":10,"featured_media":11078,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-post.php","format":"standard","meta":{"_eb_attr":"","site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_mbp_gutenberg_autopost":false,"fifu_image_url":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","fifu_image_alt":"Bayer busca innovar en la industria farmac\u00e9utica","footnotes":""},"categories":[6],"tags":[],"class_list":["post-11076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-post-agronegocios"],"yoast_head":"\nBayer busca innovar en la industria farmac\u00e9utica · Prime Action Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayer busca innovar en la industria farmac\u00e9utica · Prime Action Consulting\" \/>\n<meta property=\"og:description\" content=\"Adem\u00e1s de esta l\u00ednea, la firma tiene la intenci\u00f3n de impulsar su crecimiento tambi\u00e9n en la de consumo y agricultura.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Prime Action Consulting\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-14T14:00:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg\" \/>\n<meta name=\"author\" content=\"primeactionmx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"primeactionmx\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bayer busca innovar en la industria farmac\u00e9utica · Prime Action Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/","og_locale":"es_ES","og_type":"article","og_title":"Bayer busca innovar en la industria farmac\u00e9utica · Prime Action Consulting","og_description":"Adem\u00e1s de esta l\u00ednea, la firma tiene la intenci\u00f3n de impulsar su crecimiento tambi\u00e9n en la de consumo y agricultura.","og_url":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/","og_site_name":"Prime Action Consulting","article_published_time":"2021-07-14T14:00:35+00:00","og_image":[{"url":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","type":"","width":"","height":""}],"author":"primeactionmx","twitter_card":"summary_large_image","twitter_image":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","twitter_misc":{"Escrito por":"primeactionmx","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/"},"author":{"name":"primeactionmx","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471"},"headline":"Bayer busca innovar en la industria farmac\u00e9utica","datePublished":"2021-07-14T14:00:35+00:00","mainEntityOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/"},"wordCount":768,"publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","articleSection":["Post Agronegocios"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/","url":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/","name":"Bayer busca innovar en la industria farmac\u00e9utica · Prime Action Consulting","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","datePublished":"2021-07-14T14:00:35+00:00","breadcrumb":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#primaryimage","url":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","contentUrl":"https:\/\/cdn.forbes.com.mx\/2018\/06\/bayer.jpg1_.jpg","caption":"Bayer busca innovar en la industria farmac\u00e9utica"},{"@type":"BreadcrumbList","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-busca-innovar-en-la-industria-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/backup.primeaction.com\/sp\/"},{"@type":"ListItem","position":2,"name":"Bayer busca innovar en la industria farmac\u00e9utica"}]},{"@type":"WebSite","@id":"https:\/\/backup.primeaction.com\/sp\/#website","url":"https:\/\/backup.primeaction.com\/sp\/","name":"Prime Action Consulting","description":"Consultoria Especializada em Canais","publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.primeaction.com\/sp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/backup.primeaction.com\/sp\/#organization","name":"Prime Action Consulting","url":"https:\/\/backup.primeaction.com\/sp\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/","url":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","contentUrl":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","width":400,"height":185,"caption":"Prime Action Consulting"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471","name":"primeactionmx","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","caption":"primeactionmx"},"url":"https:\/\/backup.primeaction.com\/sp\/author\/primeactionmx\/"}]}},"_links":{"self":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/11076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/comments?post=11076"}],"version-history":[{"count":1,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/11076\/revisions"}],"predecessor-version":[{"id":11077,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/11076\/revisions\/11077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media\/11078"}],"wp:attachment":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media?parent=11076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/categories?post=11076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/tags?post=11076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}